A detailed history of Boston Partners transactions in Mesa Laboratories Inc stock. As of the latest transaction made, Boston Partners holds 4,627 shares of MLAB stock, worth $655,645. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,627
Previous 8,353 44.61%
Holding current value
$655,645
Previous $1.08 Million 43.73%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

SELL
$98.59 - $135.91 $367,346 - $506,400
-3,726 Reduced 44.61%
4,627 $610,000
Q3 2024

Nov 12, 2024

BUY
$87.73 - $140.86 $142,824 - $229,320
1,628 Added 24.21%
8,353 $1.08 Million
Q2 2024

Aug 13, 2024

BUY
$84.94 - $122.22 $571,221 - $821,929
6,725 New
6,725 $583,000

Others Institutions Holding MLAB

About MESA LABORATORIES INC


  • Ticker MLAB
  • Exchange NASDAQ
  • Sector Technology
  • Industry Scientific & Technical Instruments
  • Shares Outstandng 5,317,270
  • Market Cap $753M
  • Description
  • Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the ...
More about MLAB
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.